In the big scheme of things, the company is bringing in 11 million a year in royalties and climbing, market value under 300 million.
Back pain phase 3 product that reduces back pain
CHF phase 3 product that reduces 3 point mace, overall survival, non fatal heart attack and strokes
GvHD phase 3 product that reduces mortality
Crohns phase 1/2 product that had 4 patients all in remission
Yes - usually FDA need 1 more trial. So thats' what MSB should do.
Forget the share price, the cells work. Get the cash, partner up and get going !
With 70 million in the bank, and plenty of funding options, not as grim as people think
- Forums
- ASX - By Stock
- MSB
- Why a trial?
Why a trial?, page-28
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.0¢ |
Change
-0.045(4.52%) |
Mkt cap ! $1.093B |
Open | High | Low | Value | Volume |
$1.00 | $1.01 | 95.0¢ | $1.728M | 1.778M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 187866 | 95.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.5¢ | 108146 | 53 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 281820 | 0.950 |
10 | 111701 | 0.945 |
18 | 264844 | 0.940 |
11 | 540789 | 0.935 |
7 | 92964 | 0.930 |
Price($) | Vol. | No. |
---|---|---|
0.955 | 99357 | 51 |
0.960 | 51728 | 19 |
0.965 | 92392 | 10 |
0.970 | 90807 | 9 |
0.975 | 62224 | 5 |
Last trade - 14.21pm 20/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |